AstraZeneca Adds High-Tech Biologics Bulk Manufacturing Facility In Boulder, Colorado
09/11/2015
Pam Cheng, Executive Vice-President, Operations and Information Technology at AstraZeneca, said, “The addition of the Boulder facility will support the progression of biotech drug candidates across our main therapeutic areas as we continue to bring innovative new treatments to patients. This site will play an important role in our future commercial production and give AstraZeneca and MedImmune, our global biologics research and development arm, the flexibility and capacity to meet the needs of our rapidly growing biologics portfolio.”
Over time, the LakeCentre facility, in Boulder, will increase manufacturing and production capacity to support the company’s extensive portfolio of biologics medicines. AstraZeneca plans to start staffing the facility immediately to support refurbishment and infrastructure improvements. Once complete, the site is expected to be operational and licensed for commercial production by late 2017, providing for additional capacity within the company’s biologics operations.
In the longer- term, this site could create up to 400 highly skilled jobs, subject to relevant approvals by the local authorities, company officials said. The facility will eventually double the biologics manufacturing capacity in the US to meet the needs of the maturing AstraZeneca pipeline. Currently biologics make up 50 percent of the company’s pipeline with more than 120 ongoing programmes, including over 30 in clinical development.
Project Announcements
Dana Canada Corporation Expands Oakville-Cambridge, Ontario, Canada, Operations
12/04/2023
Sparta Metal Processing Expands White County, Tennessee, Operations
12/01/2023
Walinga USA Expands Wayland, Michigan, Operations
12/01/2023
Amkor Technology Plans Peoria, Arizona, Advanced Packaging-Test Facility
12/01/2023
Dai Nippon Printing Plans Linwood, North Carolina, Lithium-ion Manufacturing Operations
11/29/2023
Axle Logistics Expands Knoxville, Tennessee, Operations
11/29/2023
Most Read
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
The Rise of Mid-Size U.S. Cities: The Industrial Development Boom
Q3 2023
-
Front Line: Brownfields Offer Redevelopment Opportunities
Q4 2023
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
2023 Top States Commentary: Top-Ranked States Have What It Takes to Win Mega Projects
Q3 2023
-
Immigration: A Potential Fix for Labor Shortages?
Workforce Q4 2023
-
2023 Top States Workforce Development Programs
Q3 2023